137 related articles for article (PubMed ID: 21220616)
1. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.
Gergis U; Dax H; Ritchie E; Marcus R; Wissa U; Orazi A
J Clin Oncol; 2011 Apr; 29(10):e251-3. PubMed ID: 21220616
[No Abstract] [Full Text] [Related]
2. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.
Abidi MH; Tove I; Ibrahim RB; Maria D; Peres E
Am J Hematol; 2007 Oct; 82(10):932-3. PubMed ID: 17617785
[TBL] [Abstract][Full Text] [Related]
3. Histiocytic sarcoma arising from clonally related mantle cell lymphoma.
Hure MC; Elco CP; Ward D; Hutchinson L; Meng X; Dorfman DM; Yu H
J Clin Oncol; 2012 Feb; 30(5):e49-53. PubMed ID: 22184374
[No Abstract] [Full Text] [Related]
4. Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature.
Saboo SS; Krajewski KM; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya N
Cancer Imaging; 2012 Aug; 12(1):253-8. PubMed ID: 22935131
[TBL] [Abstract][Full Text] [Related]
5. A case of stage IV neuroblastoma treated with aggressive surgery following intensive neoadjuvant chemotherapy with autologous stem cell transplantation.
Yamamoto Y; Makimoto A
Jpn J Clin Oncol; 2012 Apr; 42(4):359. PubMed ID: 22457363
[No Abstract] [Full Text] [Related]
6. A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant.
Mainardi C; D'Amore ES; Pillon M; Toffolutti T; Rosolen A
Leuk Lymphoma; 2011 Jul; 52(7):1367-71. PubMed ID: 21425962
[No Abstract] [Full Text] [Related]
7. Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse.
Mattei D; Mordini N; Vigna Taglianti R; Bruno B; Rapezzi D; Gallamini A
Haematologica; 2005 Jun; 90(6):861-2. PubMed ID: 15951306
[TBL] [Abstract][Full Text] [Related]
8. Histiocytic sarcoma in the small intestine: a case report with flow cytometry study and review of the literature.
Zhang X; Kryston JJ; Michalak WA; Zhang K; Lin F; Schuerch C
Pathol Res Pract; 2008; 204(10):763-70. PubMed ID: 18541386
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR
Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
11. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
[No Abstract] [Full Text] [Related]
14. Multiple myeloma in a 50-year-old with an HLA-identical sibling.
Koreth J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1247-8. PubMed ID: 17889363
[No Abstract] [Full Text] [Related]
15. [Histiocytic sarcoma of the small intestine: Report of one case].
Avilés-Salas A; Peña-Torres Mde L; Molina-Cruz A; Rivas-Vera S
Rev Med Chil; 2009 Feb; 137(2):269-74. PubMed ID: 19543651
[TBL] [Abstract][Full Text] [Related]
16. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
[TBL] [Abstract][Full Text] [Related]
17. [Histiocytic sarcoma].
Létalová E; Moulis M; Klincová M; Koukalová R; Rehák Z; Folber F; Adam Z; Mayer J
Vnitr Lek; 2013 Dec; 59(12):1117-22. PubMed ID: 24350943
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Petkova NY; Hristoskova RG; Guenova ML; Raynov JI
Folia Med (Plovdiv); 2018 Jun; 60(2):318-322. PubMed ID: 30355826
[TBL] [Abstract][Full Text] [Related]
19. Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
Tosi P; Ronconi S; Zamagni E; Cellini C; Grafone T; Cangini D; Pileri SA; Baccarani M; Tura S; Cavo M
Haematologica; 2001 Apr; 86(4):409-13. PubMed ID: 11325648
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
